Digistat Care
Ascom Ums Srl Unipersonale · Decision date Sep 12, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for Digistat Care, submitted by Ascom Ums Srl Unipersonale of Scandicci, Italy, under 510(k) number K261287. The decision date is September 12, 2026, and the application was received April 20, 2026. The device is listed under regulation 870.2300, classification name System, Network and Communication, Physiological Monitors, with primary product code MSX and subsequent product code PHC; the regulation medical specialty and review panel are both Cardiovascular. SESE in this context is a 510(k) clearance, not a premarket approval.
The reviewed document describes Digistat Care as software that transfers, stores, elaborates, organizes and displays patient information, generates alarm signals for user notification based on signals determined and sent by compatible medical devices, and exchanges information with systems not associated with active patient monitoring. It is intended for trained healthcare professionals in professional healthcare facilities and not for home use. The public record notes a traditional summary, no third-party review, no combination product, and no authorized predetermined change control plan.
The record does not identify a predicate device, the specific cleared modifications, or performance data supporting the clearance, and no clinical or efficacy conclusions are drawn here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 12, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261287
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Ascom Ums Srl Unipersonale
- Product code
- MSX
- Decision code
- SESE
- Decision date
- Sep 12, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Network And Communication, Physiological Monitors.
- Applicant
- Ascom Ums Srl Unipersonale
- Product code
- MSX
- FDA device class
- 2
FDA decision timeline
K261287 received
Application receipt date recorded by FDA.
K261287 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MSX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
eClinicsK260075 | Ceiba Healthcare US, Inc. | 510(k) clearance | Oct 7, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Ascom Ums Srl Unipersonale
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Scandicci (Fi)
Sources and methodology
- Original FDA record: K261287
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records